116 related articles for article (PubMed ID: 31957550)
41. Laparoscopic augmentation enterocystoplasty through a single trocar.
Noguera RJ; Astigueta JC; Carmona O; De Andrade RJ; Luis S; Cuomo B; Manrique J; Gill IS; Desai MM
Urology; 2009 Jun; 73(6):1371-4. PubMed ID: 19362340
[TBL] [Abstract][Full Text] [Related]
42. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous augmentation cystoplasty and cuff only artificial urinary sphincter in children and young adults with neurogenic urinary incontinence.
Viers BR; Elliott DS; Kramer SA
J Urol; 2014 Apr; 191(4):1104-8. PubMed ID: 24060640
[TBL] [Abstract][Full Text] [Related]
44. Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida.
Joseph DB; Borer JG; De Filippo RE; Hodges SJ; McLorie GA
J Urol; 2014 May; 191(5):1389-95. PubMed ID: 24184366
[TBL] [Abstract][Full Text] [Related]
45. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
Tilki D; Svatek RS; Karakiewicz PI; Novara G; Seitz M; Sonpavde G; Gupta A; Kassouf W; Fradet Y; Ficarra V; Skinner E; Lotan Y; Sagalowsky AI; Stief CG; Reich O; Shariat SF
J Urol; 2010 Aug; 184(2):470-4. PubMed ID: 20620401
[TBL] [Abstract][Full Text] [Related]
46. Ureterocystoplasty: the 'bladder' augmentation of choice.
Hitchcock RJ; Duffy PG; Malone PS
Br J Urol; 1994 May; 73(5):575-9. PubMed ID: 8012783
[TBL] [Abstract][Full Text] [Related]
47. Adenocarcinoma arising in a gastrocystoplasty.
Balachandra B; Swanson PE; Upton MP; Yeh MM
J Clin Pathol; 2007 Jan; 60(1):85-7. PubMed ID: 17213351
[TBL] [Abstract][Full Text] [Related]
48. Long-Term Outcomes of Bladder Neck Reconstruction without Augmentation Cystoplasty in Children.
Grimsby GM; Menon V; Schlomer BJ; Baker LA; Adams R; Gargollo PC; Jacobs MA
J Urol; 2016 Jan; 195(1):155-61. PubMed ID: 26173106
[TBL] [Abstract][Full Text] [Related]
49. Tissue engineered cystoplasty augmentation for treatment of neurogenic bladder using small intestinal submucosa: an exploratory study.
Zhang F; Liao L
J Urol; 2014 Aug; 192(2):544-50. PubMed ID: 24681330
[TBL] [Abstract][Full Text] [Related]
50. [Radical cystectomy in the treatment of bladder cancer always in due time?].
May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
[TBL] [Abstract][Full Text] [Related]
51. [Augmentation cystoplasty for severe uropathy in children].
Jaureguízar E; López Pereira P; López Gutiérrez J
Cir Pediatr; 1991 Jan; 4(1):39-44. PubMed ID: 2043435
[TBL] [Abstract][Full Text] [Related]
52. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.
Shariat SF; Chade DC; Karakiewicz PI; Ashfaq R; Isbarn H; Fradet Y; Bastian PJ; Nielsen ME; Capitanio U; Jeldres C; Montorsi F; Lerner SP; Sagalowsky AI; Cote RJ; Lotan Y
J Urol; 2010 Jan; 183(1):68-75. PubMed ID: 19913255
[TBL] [Abstract][Full Text] [Related]
53. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
54. Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study.
Anderson JA; Matoso A; Murati Amador BI; Cheng L; Stohr BA; Chan E; Osunkoya AO
Pathology; 2021 Feb; 53(2):214-219. PubMed ID: 32951908
[TBL] [Abstract][Full Text] [Related]
55. Functional outcome and specific complications of gastrocystoplasty for failed bladder exstrophy closure.
El-Ghoneimi A; Muller C; Guys JM; Coquet M; Monfort G
J Urol; 1998 Sep; 160(3 Pt 2):1186-9. PubMed ID: 9719306
[TBL] [Abstract][Full Text] [Related]
56. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
57. The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder.
Bella AJ; Stitt LW; Chin JL; Izawa JI
J Urol; 2003 Dec; 170(6 Pt 1):2253-7. PubMed ID: 14634391
[TBL] [Abstract][Full Text] [Related]
58. Augmentation enterocystoplasty without reimplantation for patients with neurogenic bladder and vesicoureteral reflux.
Zhang HC; Yang J; Ye X; Hu HF
Kaohsiung J Med Sci; 2016 Jun; 32(6):323-6. PubMed ID: 27377846
[TBL] [Abstract][Full Text] [Related]
59. Long-term follow up of enteric bladder augmentations: the risk for malignancy.
Husmann DA; Rathbun SR
J Pediatr Urol; 2008 Oct; 4(5):381-5; discussion 386. PubMed ID: 18653384
[TBL] [Abstract][Full Text] [Related]
60. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
